Case Study: Epilepsy (Seizure Disorder)
Patient Information:
Treatment: Minimally Invasive Brain Surgery for Seizure Disorder (Functional Stereotaxy) with Daily Intravenous (IV) Neurological Nutritional Support, Neural Growth Factors Injection, Neural Cell Activation & Proliferation Therapy, and Rehabilitation Therapy
History:
Cecille Horgen, a 24-year-old woman from Norway, was admitted to Beijing Puhua International Hospital due to "intermittent seizures for 17 years and no speech communication for 5 years." She had previously undergone surgery at the age of eight to remove an arachnoid cyst in her right ventricle. Although the operation initially resolved her condition, Cecille subsequently developed a seizure disorder and lost most of her language skills.
Medical Condition Before Minimally Invasive Brain Surgery:
Prior to stereotactic treatment, Cecille had not spoken for five years. She maintained a stiff and straight body posture with her hands on her legs (both awake and asleep). She did not communicate verbally or make eye contact with her family members. She was highly sensitive and anxious around strangers.
Minimally Invasive Brain Surgery:
Cecille underwent stereotactic destruction of the nucleus with injections of neural growth factors, neural cell activation & proliferation therapy, and rehabilitation therapy.
Medical Condition After Minimally Invasive Brain Surgery:
Following stereotactic therapy for seizure disorder:
Follow-Up:
18 February 2011 – Cecille's family reported that her seizures had become significantly less frequent. She also started speaking more often, demonstrating increased mental clarity, expressiveness, and an overall improvement in her general situation since undergoing Stereotactic Therapy at Beijing Puhua International Hospital.